The Potential Benefits of Senolytics (Dasatinib and Quercetin) for Anti-Aging
Senolytics, a promising approach to anti-ageing?
Senolytics like Dasatinib and Quercetin could not only offer a promising approach to treating osteoarthritis but also have positive effects in the realm of anti-aging. These medications target senescent cells, also known as “zombie cells,” selectively eliminating them, potentially slowing down the progression and symptoms of osteoarthritis while simultaneously slowing the aging process.
Talk to us on 069 50 50 00 948 or send us an e-mail using the contact form.
Reduction of Inflammation and Aging Signs
Senolytics have the potential to reduce inflammation associated with osteoarthritis and the aging process. By eliminating senescent cells, senolytics could not only improve joint health but also reduce age-related inflammation throughout the body.
Improvement of tissue integrity
Senolytics could help maintain the integrity of cartilage tissue and other tissues that deteriorate with aging. This could lead to improved joint function and overall higher quality of life.
Promotes the regeneration of collagen and elastin
Senolytics could stimulate the production of collagen and elastin, essential proteins for the health of skin, bones, and other tissues. This could result in firmer, more elastic skin and reduced susceptibility to injuries.
Delaying the ageing process
y selectively eliminating senescent cells, senolytics could slow down the aging process and extend lifespan. This could lead to improved health in old age and reduced susceptibility to age-related diseases.
While further research is needed to fully understand the effects of senolytics on the aging process and overall health, preliminary studies suggest that these medications have promising potential to enhance both quality of life and longevity.